Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 1062 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
 
ORIGINAL ARTICLE
Ahead of Print

Comparative study between chronic automated red blood cell exchange and manual exchange transfusion in patients with sickle cell disease: A single center experience from Saudi Arabia


1 Department of Pathology and Laboratory Medicine, King Fiasal Specialised Hospital, Riyadh, Saudi Arabia
2 Department of Blood Bank, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
3 Department of Blood Bank, College of Medicine, King Saud University, Riyadh, Saudi Arabia
4 Department of Pharmacy, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
5 Department of Hematology, Whittington Health, London, UK
6 Department of Pathology, School of Medicine, Saint Louis University, St. Louis, Missouri, United States
7 Oncology Centre, Section of Adult Hematology/HSCT, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
8 Department of Clinical Pathology, Laboratory Hematology, Ain Shams University Hospitals, Cairo, Egypt
9 Oncology Centre, Section of Adult Hematology/HSCT, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia; Department of Internal Medicine/Adult Hematology, Ain Shams University Hospital, Cairo, Egypt

Correspondence Address:
Mervat Abdalhameed Alfeky,
Department of Clinical Pathology, Ain Shams University Hospitals, Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ajts.ajts_13_21

BACKGROUND: Red cell transfusion remains the gold standard in managing sickle cell disease (SCD) with severe complications. Offering red blood cell exchange (RBCX) either manual exchange transfusion (MET) or automated RBCX (aRBCX) can reduce the complications of chronic transfusion and maintain target Hb thresholds. This study audits the hospital experience of overseeing adult SCD patients treated with RBCX, both automated and manual, and compares the safety and efficacy. MATERIALS AND METHODS: This retrospective observational study was conducted as an audit for chronic RBCX for adult patients with SCD in 2015–2019 at King Saud University Medical City, Riyadh, Saudi Arabia. RESULTS: A total of 344 RBCX for 20 adult SCD patients who were enrolled in regular RBCX, (11/20) patients had regular aRBCX with a total of (157) sessions, and (9/20) patients had MET with a total of (187) sessions. The median level of HbS% post-aRBCX was significantly lower than MET (24.5.9% vs. 47.3%, P < 0.010). Patients on aRBCX had fewer sessions (5 vs. 7.5, P < 0.067) with better disease control. Although the median yearly pRBC units per patient for aRBCX was more than the double needed for MET (28.64 vs. 13.39, P < 0.010), the median ferritin level was 42 μg/L in aRBCX versus 983.7 μg/L in MET, P < 0.012. CONCLUSION: Compared to MET, aRBCX was more effective in reducing HbS, with fewer hospital visits and better disease control. Although more pRBCs were transfused, the ferritin level was better controlled in the aRBCX group without increasing alloimmunization risk.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Al Mozain N
    -  Elobied Y
    -  Al-Omran A
    -  Aljaloud A
    -  Omair AB
    -  Tuwaim RB
    -  Alkhalifah S
    -  Altawil ES
    -  Abraham S
    -  Salcedo LR
    -  Parena A
    -  Shah F
    -  Ayyoubi M T
    -  Hermelin D
    -  Al Gahtani F
    -  Alfeky MA
    -  El Gohary G
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed713    
    PDF Downloaded36    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Copyright and Disclaimer | Privacy Notice


2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006